| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5879342 | The Journal of Pain | 2009 | 11 Pages |
Abstract
This study presents efficacy and safety results of a phase 3, double-blind, placebo-controlled trial of the anticonvulsant drug lacosamide in patients with painful diabetic neuropathy. Lacosamide treatment at a dose of 400 mg/day reduced diabetic neuropathic pain with a favorable safety and tolerability profile that may be suitable for patients with diabetes.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Aziz Shaibani, Salah Fares, Jean-Louis Selam, Armen Arslanian, Jeffrey Simpson, David Sen, Sabine Bongardt,